ANIX
ANIX
NASDAQ · Biotechnology

Anixa Biosciences Inc

$2.72
+0.04 (+1.49%)
As of Nov 14, 2:27 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +458.1% upside
Low Target $12.50
Average Target $15.18
High Target $18.81
Current Price $2.72
Current
$2.72
Target
$15.18
$12.50 $15.18 avg $18.81
Scenario Analysis
Bear Case
$12.50
359.6%
Low target
Base Case
$15.18
+458.1%
Avg target
Bull Case
$18.81
+591.5%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$5.46
-50.2% from high
52-Week Low
$2.32
+17.2% from low
Target vs 52W High
$15.18
+178.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%